ADICON Issues Supplemental Update on 100% Acquisition of Crown Bioscience; Circular Targeted for Dispatch by 30 September 2026
Bulletin Express
May 15
ADICON Holdings Limited has released a supplemental progress update concerning its planned purchase of the entire issued share capital of Crown Bioscience International.
The board now estimates that the shareholder circular detailing the transaction terms will be dispatched on or before 30 September 2026. Earlier updates were provided on 13 November 2025 and 13 May 2026.
Completion of the deal remains subject to the satisfaction of all agreed conditions precedent. Until those conditions are fulfilled, the acquisition may or may not proceed.
The company advises shareholders and potential investors to exercise caution when dealing in ADICON securities while the transaction remains pending.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.